Patents
Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
01/2007
01/31/2007EP1747199A1 Pyrrolidin-2-one and piperidin-2-one derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors
01/31/2007EP1747196A2 Substituted aryl acylthioureas and related compounds; inhibitors of viral replication
01/31/2007EP1747021A2 Self-immolative linkers and drug conjugates
01/31/2007EP1746880A1 Quinoxalin-2-one derivatives crop protection agents comprising the same and method for production and use therof
01/31/2007CN1906190A 选择性激酶抑制剂 Selective kinase inhibitor
01/31/2007CN1906178A 喹唑啉衍生物 Quinazoline derivatives
01/31/2007CN1906174A Novel benzimidazole and imidazopyridine derivatives and use thereof as a medicament
01/31/2007CN1906173A Protein modifier production inhibitor
01/31/2007CN1906165A Novel herbicides
01/31/2007CN1906163A 4-phenylpiperidine derivatives as renin inhibitors
01/31/2007CN1906146A Process for producing epoxytriazole compound and intermediate therefor
01/31/2007CN1905872A Amino substituted pyridinyl methanone compounds useful in treating kinase disorders
01/31/2007CN1903853A Synthesis of 8-(4,6-dimethoxy pyrimidine oxy)-2-substituted phentriazine-1-one derivative and its herbicide activity
01/31/2007CN1297550C Benzofuran derivatives, process for the preparation of the same and uses thereof
01/31/2007CN1297546C Derivatives of N-(arylsulfonyl) beta-aminoacids comprising substituted aminomethyl group, prepn. method thereof and pharmaceutical compsns. contg same
01/31/2007CN1297281C Method for treatment of leukaemia
01/30/2007US7169942 Cannabinoid derivatives, methods of making, and use thereof
01/30/2007US7169935 Process for preparing heterocyclic indene analogs
01/30/2007US7169932 HIV protease inhibitors, compositions containing the same, their pharmaceutical uses, material for their synthesis
01/30/2007US7169930 Analogs of epothilone
01/30/2007US7169927 Heterocyclic amides or prodrugs used in the treatment of diabetes, insulin resistance, metabolic disorders and obesity
01/30/2007US7169925 Indole derivatives as interleukin-4 gene expression inhibitors
01/30/2007US7169924 Pyrimidinone derivatives and their use in the treatment of atherosclerosis
01/30/2007US7169907 Derivatives, immunogens, and antibodies for detecting ecstasy-class drugs
01/30/2007US7169800 For cancer therapy
01/30/2007US7169795 For use as anticoagulant agents for therapy of thromboembolic disorders
01/30/2007US7169791 Inhibitors of tyrosine kinases
01/30/2007US7169785 e.g., 2-{[4-(Cyclohexylmethyl-amino)-6-(3-fluoro-4-methoxy-phenylamino)-[1,35]triazin-2-ylamino]-methyl}-cyclopentanone; treating unwanted cellular proliferation, an inflammation mediated disease, or a hyperproliferative disease, or modulating a glycosidase enzyme
01/30/2007US7169784 Medical devices employing triazine compounds and compositions thereof
01/30/2007US7169775 Amino methyl imidazoles as C5a receptor modulators
01/30/2007US7169772 Vasopressin active material; antidiabetic agents; diuretics; bioavailability
01/30/2007US7169766 Administering nucleoside, or prodrug thereof; viricides
01/30/2007US7169558 Using non-radioactive markers to identify nascent proteins translated within cellular or cell-free translation systems; bioremediation and pollution contol of biohazards
01/30/2007CA2350573C Piperidines as ccr5 modulators
01/30/2007CA2238316C N-([1,2,4]triazoloazinyl)benzenesulfonamide and pyridinesulfonamide compounds and their use as herbicides
01/30/2007CA2214322C Novel taxoids, preparation thereof, and pharmaceutical compositions containing same
01/30/2007CA2207628C 3-aryl-1,2,4-triazole derivatives with herbicidal properties
01/30/2007CA2163747C Novel 1-phenylalkanone 5-ht4 receptor ligands
01/25/2007WO2007011721A1 Inhibitors of mitotic kinesin
01/25/2007WO2007011623A1 Quinazoline derivatives useful in cancer treatment
01/25/2007WO2007011618A1 Quinazoline derivatives useful in cancer treatment
01/25/2007WO2007010946A1 Synovial cell proliferation inhibitor
01/25/2007WO2007010383A1 Novel heterocyclidene acetamide derivative
01/25/2007WO2007009774A1 Benzimidazole derivatives for treatment of inflammatory diseases
01/25/2007WO2007009741A1 Piperazinone derivatives useful as histamine h3 receptor antagonists and/or inverse agonists
01/25/2007WO2007009670A1 4-chromenonyl-1,4-dihydropyridinecarbonitriles and the use thereof
01/25/2007WO2007009662A1 Substituted piperidine derivatives as somatostatin sst1 receptor antagonists
01/25/2007WO2006131303A3 Peptide deformylase (pdf) inhibitors 4
01/25/2007WO2006113864A3 Oxindole compounds and their uses as therapeutic agents
01/25/2007WO2006086358A3 Mitotic kinesin inhibitors
01/25/2007WO2005090336A8 2-propanol and 2-propylamine derivatives and their use as glucocorticoid ligands
01/25/2007US20070021623 Novel process for preparation of nebivolol intermediates
01/25/2007US20070021609 4-phenylpiperazin-1-yl)acylpiperidine derivatives, preparation thereof and application of same in therapeutics
01/25/2007US20070021509 Phosphate transport inhibitors
01/25/2007US20070021494 3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands
01/25/2007US20070021482 1,5,7-Trisubstituted benzimidazole derivatives and their use for modulating the gabaa receptor complex
01/25/2007US20070021464 Methods and compositions for inhibition of angiogenesis with EM-12 Derivatives
01/25/2007US20070021456 Aminobenzimidazole derivatives
01/25/2007US20070021440 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same
01/25/2007US20070021420 New derivatives of hydantoins, thiohydantoins, pyrimidinediones and thioxopyrimidinones, their preparation processes and their use as medicaments
01/25/2007US20070021414 1-'2-(4-Hydroxyphenyl)-2-hydroxyethyl!-piperidin-4-ol compounds as nmda receptor antagonists
01/25/2007US20070021410 Such as N-[1-(2-amino-3-methylbutyl)-4-piperidinyl]-3-[(2-methoxyethoxy)(6-methyl-2-pyridinyl)methyl]-7-methyl-3H-imidazo[4,5-b]pyridin-2-amine; infant infections
01/25/2007US20070021407 Substituted quinolines as antitumor agents
01/25/2007US20070021390 thiazole, oxazole derivatives useful for treating neurodegenerative disorders or pain
01/25/2007US20070021386 Azole derivatives and fused bicyclic azole derivatives as therapeutic agents
01/25/2007US20070021355 Antidepressants or foods and beverage for antidepression
01/25/2007US20070021354 Viricides; immunomoderator; mixture with other Aids drugs
01/25/2007US20070020643 High affinity for streptavidin/avidin; biotinyl moiety linked to a photoreactive group covalently bound to substrate (proteins, peptides, amino acids, and nucleic acids); Exposure of the conjugate to radiation releases the target in a functional form and completely unaltered
01/25/2007DE102005034267A1 New 4-chromenonyl-1,4-dihydropyridine derivatives, useful for treatment of e.g. aldosteronism, hypertension and cardiac insufficiency, are antagonists of the mineralcorticoid receptor
01/25/2007DE102005034266A1 New 8-dihydropyridyl-chromene derivatives, are antagonists of the mineralcorticoid receptor, useful for treatment and prevention of e.g. aldosteronism, hypertension and cardiac insufficiency
01/25/2007DE102005034263A1 New 8-dihydropyridyl-chromene derivatives, useful for treatment and prevention of e.g. aldosteronism, hypertension and cardiac insufficiency, are antagonists of the mineralcorticoid receptor
01/25/2007CA2615434A1 Perfluoroalkyl-containing complexes, process for their production as well as their use
01/25/2007CA2615380A1 Quinazoline derivatives useful in cancer treatment
01/25/2007CA2615373A1 Quinazoline derivatives useful in cancer treatment
01/25/2007CA2615236A1 Substituted piperidine derivatives as somatostatin sst1 receptor antagonists
01/25/2007CA2615105A1 Histone deacetylase inhibitors
01/25/2007CA2612469A1 Benzimidazole derivatives for treatment of inflammatory diseases
01/24/2007EP1745042A1 Diarylamine derivatives as calcium channel blockers
01/24/2007EP1745041A2 Quinoxaline inhibitors of the hedgehog signalling pathway
01/24/2007EP1745040A1 Azabicyclo(3.1.0) hexane derivatives useful as modulators of dopamine d3 receptors
01/24/2007EP1745039A2 3-aryl-5,6-disubstituted pyridazines
01/24/2007EP1745038A1 Fused heteroaryl derivatives for use as p38 kinase inhibitors in the treatment of i.a. rheumatoid arthritis
01/24/2007EP1745033A2 4,5-disubstituted-2-aryl pyrimidines
01/24/2007EP1745024A1 1-aryl-4-substituted isoquinolines
01/24/2007EP1745019A1 Novel compounds of proline and morpholine derivatives
01/24/2007EP1745015A1 Bicyclic aromatic sulfinyl derivatives
01/24/2007EP1453492B1 Use of quinazolines to treat t-cell mediated diseases
01/24/2007EP1408964B1 Use of 2- 5-(4-fluorophenyl)-3-pyridylmethylaminomethyl|-chromane and its physiologically acceptable salts
01/24/2007EP1377555B1 A dioxino[2,3-g]quinoline-9-carboxylic acid derivative as nk3 receptor antagonist
01/24/2007EP1363900B1 Isoindole-imide compounds, compositions and uses thereof
01/24/2007EP1341537B1 Pharmaceutically active isoindoline derivatives
01/24/2007EP1072598B9 Pyrazolinone derivatives
01/24/2007EP0968206B8 N-heterocyclic derivatives as nos inhibitors
01/24/2007CN1902194A Process for preparing amorphous (4r-cis)-6-[2-[3-phenyl-4-(phenylcarbamoyl)-2-(4-fluorophenyl)-5-(1-methyl)-pyrrol-1-yl]-2,2-dimethyl-[1,3]-dioxane-4-yl-acetic acid
01/24/2007CN1902191A Amidopyrazole derivative
01/24/2007CN1902181A Benzimidazoles useful as modulators of ion channels
01/24/2007CN1902179A Methods and compositions for selectin inhibition
01/24/2007CN1902172A N-acylated-3- (benzoyl) - pyrrolidines as 11-beta-hsd1 inhibitors useful for the treatment of metabolic disorders
01/24/2007CN1902171A Benzylether amine compounds useful as CCR-5 antagonists
01/24/2007CN1901910A Substituted piperidines for the treatment of metabolic syndrome